Tower Research Capital LLC (TRC) - EYEPOINT PHARMACEUTICALS INC ownership

EYEPOINT PHARMACEUTICALS INC's ticker is EYPT and the CUSIP is 30233G100. A total of 64 filers reported holding EYEPOINT PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 0.47 and the average weighting 0.5%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of EYEPOINT PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2020$9,000
-25.0%
17,615
+10.8%
0.00%
Q2 2020$12,000
+100.0%
15,894
+173.1%
0.00%
Q1 2020$6,000
+100.0%
5,819
+250.1%
0.00%
Q4 2019$3,000
-25.0%
1,662
-20.2%
0.00%
Q3 2019$4,000
-69.2%
2,082
-73.5%
0.00%
-100.0%
Q2 2019$13,000
-78.7%
7,852
-76.7%
0.00%
-75.0%
Q1 2019$61,00033,7300.00%
Other shareholders
EYEPOINT PHARMACEUTICALS INC shareholders Q4 2019
NameSharesValueWeighting ↓
Essex Woodlands Management, Inc. 41,909,219$21,793,00011.58%
Kore Private Wealth LLC 202,366$105,0000.02%
BARD ASSOCIATES INC 335,750$175,0000.02%
HighTower Advisors, LLC 5,284,688$2,738,0000.01%
GSA CAPITAL PARTNERS LLP 126,529$66,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 654,200$339,0000.01%
Virtu Financial LLC 57,076$30,0000.01%
WEDBUSH SECURITIES INC 81,500$42,0000.00%
NEXPOINT ASSET MANAGEMENT, L.P. 33,933$18,0000.00%
MATRIX ASSET ADVISORS INC/NY 39,500$20,0000.00%
View complete list of EYEPOINT PHARMACEUTICALS INC shareholders